- Home
- INM vs NXPLW Comparison
INM vs NXPLW Comparison
Compare INM & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- NXPLW
- Stock Information
- Founded
- INM 1981
- NXPLW N/A
- Country
- INM Canada
- NXPLW United States
- Employees
- INM N/A
- NXPLW 166
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- NXPLW Telecommunications Equipment
- Sector
- INM Health Care
- NXPLW Telecommunications
- Exchange
- INM Nasdaq
- NXPLW Nasdaq
- Market Cap
- INM 3.2M
- NXPLW N/A
- IPO Year
- INM N/A
- NXPLW N/A
- Fundamental
- Price
- INM $3.00
- NXPLW $0.16
- Analyst Decision
- INM
- NXPLW
- Analyst Count
- INM 0
- NXPLW 0
- Target Price
- INM N/A
- NXPLW N/A
- AVG Volume (30 Days)
- INM 56.6K
- NXPLW 6.4K
- Earning Date
- INM 05-13-2025
- NXPLW 03-31-2025
- Dividend Yield
- INM N/A
- NXPLW N/A
- EPS Growth
- INM N/A
- NXPLW N/A
- EPS
- INM N/A
- NXPLW N/A
- Revenue
- INM $4,832,013.00
- NXPLW $66,482,000.00
- Revenue This Year
- INM N/A
- NXPLW N/A
- Revenue Next Year
- INM N/A
- NXPLW N/A
- P/E Ratio
- INM N/A
- NXPLW N/A
- Revenue Growth
- INM N/A
- NXPLW 179.89
- 52 Week Low
- INM $1.72
- NXPLW $0.25
- 52 Week High
- INM $15.70
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- INM 62.76
- NXPLW N/A
- Support Level
- INM $2.56
- NXPLW N/A
- Resistance Level
- INM $3.05
- NXPLW N/A
- Average True Range (ATR)
- INM 0.27
- NXPLW 0.00
- MACD
- INM 0.09
- NXPLW 0.00
- Stochastic Oscillator
- INM 92.98
- NXPLW 0.00
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.